Results 11 to 20 of about 57,276 (230)

Phenotypic and enzymatic comparative analysis of the KPC variants, KPC-2 and its recently discovered variant KPC-15. [PDF]

open access: yesPLoS ONE, 2014
Sixteen different variants (KPC-2 to KPC-17) in the KPC family have been reported, and most current studies are focusing on KPC-2 and KPC-3. The KPC-15 variant, which isolated from Klebsiella pneumoniae in a Chinese hospital, was a recently discovered ...
Linjun Yang (652707)   +9 more
core   +5 more sources

How to manage KPC infections [PDF]

open access: yesTherapeutic Advances in Infectious Disease, 2020
Carbapenemase-producing Enterobacteriaceae represent an increasing global threat worldwide and Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic ...
Matteo Bassetti   +3 more
core   +5 more sources

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity [PDF]

open access: yesFrontiers in Microbiology, 2020
A novel Klebsiella pneumoniae carbapenemase (KPC) variant, KPC-55, produced by a K. pneumoniae ST307 strain was characterized. K. pneumoniae strain BS407 was recovered from an active surveillance rectal swab of a patient newly admitted to a general ...
정석훈, 최종락
core   +6 more sources

Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10 [PDF]

open access: yesEurosurveillance, 2011
We report four epidemiologically unrelated cases of KPC-carrying Klebsiella pneumoniae identified in Switzerland between May 2009 and November 2010. Three cases were transferred from Italy (two KPC-3, one KPC-2) and one from Greece (KPC-2). Resistance to
Droz, S   +21 more
core   +6 more sources

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2019
International audienceBACKGROUND:KPC-like carbapenemases have spread worldwide with more than 30 variants identified that differ by single or double amino-acid substitutions.OBJECTIVES:To describe the steady-state kinetic parameters of KPC-28, which ...
Tlili, Linda   +9 more
core   +3 more sources

Identification of two KPC variants, KPC-204 and KPC-227, in ST11-K64 Klebsiella pneumoniae during prolonged hospitalization of a single patient [PDF]

open access: yesFrontiers in Microbiology
IntroductionCarbapenem-resistant Klebsiella pneumoniae (CRKP) represents a critical global public health challenge due to its significant association with morbidity and mortality.
Chaoe Zhou   +6 more
core   +4 more sources

Management of KPC-Producing Klebsiella pneumoniae Infections [PDF]

open access: yesClinical Microbiology and Infection, 2017
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic ...
E.J. Giamarellos-Bourboulis   +58 more
core   +10 more sources

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2018
The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex β-lactamase backgrounds.
Krisztina M. Papp-Wallace   +9 more
core   +3 more sources

A High-Affinity Nanobody Selectively Recognizing KPC-2/KPC-3: Biochemical and Structural Insights

open access: yesBiomolecules
International audienceCarbapenemase-producing bacteria, particularly those expressing the KPC-3 variant, pose a critical global health threat due to their resistance to nearly all β-lactam antibiotics, including carbapenems.
Perilli, Mariagrazia   +10 more
core   +3 more sources

Emergence of ceftazidime-avibactam resistance mediated by KPC variants KPC-71 and KPC-78 in ST463 <i>Pseudomonas aeruginosa</i>. [PDF]

open access: yesMicrobiol Spectr
ABSTRACT Pseudomonas aeruginosa is a well-recognized opportunistic pathogen and a leading cause of healthcare-associated infections. The shrinking effectiveness of available antimicrobial therapies has intensified the global threat posed by ...
Yang F   +12 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy